Discovery of a highly potent, selective, orally bioavailable inhibitor of KAT6A/B histone acetylt...
Sharma et al. describe the discovery and chemical optimization of a potent, selective, orally bioavailable inhibitor of KAT6A/B with anti-tumor activity in ER+ breast cancer.